BMJ · 1980 · 70 citations · 5 references
MedicinePharmacologyPharmacotherapyCardiovascular PharmacotherapyClinical PharmacologyNeuropharmacologyBlood Pressure ControlBlood Pressure ManagementHypertension ControlHypertension ManagementHypertension PharmacotherapyHypertension PreventionAntihypertensive Drug TherapyAntihypertensive PharmacologyBeta-adrenergic Blocker UseBeta-blocker UseBlood PressurePlacebo-controlled Efficacy Assessment
Twenty-four black patients (Zulus) with hypertension participated in a double-blind, placebo-controlled cross-over trial of the efficacy of a beta-blocking agent (atenolol) 100 mg once daily as compared with chlorthalidone 25 mg once daily. The two drugs were also given combined at these doses and the effects compared with those of the drugs given alone. Atenolol as sole treatment had no appreciable effect on blood pressure as compared with placebo. Chlorthalidone produced a small decrease, but this was not statistically significant. Combining the two drugs, however, produced a significant reduction in blood pressure (mean lying blood pressure p < 0.001; mean standing blood pressure p < 0.0002). These findings suggest that beta-blockers should not be regarded as baseline treatment of hypertension in blacks.
5
Treatment of Hypertension with Propranolol
B. N. C. Prichard, P. M. S. Gillam · BMJ · 1969 · 428 citations · Full text
Ineffectiveness of propranolol in hypertensive Jamaicans.
Georgina Humphreys, David Delvin · BMJ · 1968 · 107 citations · Full text
Renin, aldosterone, sodium and hypertension
Paul E. Wisenbaugh, Josephine B. Garst, Charles L. H. Hull et al. · The American Journal of Medicine · 1972 · 35 citations
Comparison of propranolol and atenolol in hypertension.
Zacharias Fj, Cowen Kj · PubMed · 1977 · 20 citations